BridgeBio Pharma (BBIO) PT Lowered to $55 at JPMorgan
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $76.57 -0.03%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 17
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 17
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on BridgeBio Pharma (NASDAQ: BBIO) to $55.00 (from $58.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- Robinhood Markets (HOOD) PT Raised to $145 at Piper Sandler
- Meesho Ltd (MESSHO:IN) PT Raised to INR236 at Axis Capital Limited
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
